Latest advances and outcomes from the treatment of acute leukemia today
Leukemia is a blood cancer that can be identified by the rapid growth of defective
blood cells. The marrow of our bone produces most of the blood in our body which is
the site of this abnormal growth. Typically, leukemia cells are immature white blood
cells. Leukemic cells alter the normal blood cell formation process, leading to various
signs and symptoms such as bleeding, infection, and tiredness.
There are two kinds of leukemia: acute leukemia and chronic leukemia. Further, the
acute type was classified into acute myeloid leukaemia (AML) and acute
lymphoblastic leukaemia (ALL). Myeloblasts, or defective white blood cells, are the
cause of acute myeloid leukaemia (AML). Acute myelogenous, granulocytic,
nonlymphocytic, or myeloblastic leukaemia are other terms for this kind of cancer.
However, the overproduction of lymphocytes is caused by acute lymphoblastic
leukaemia (ALL).
Stem cell transplantation, radiation therapy, and chemotherapy have been the
cornerstones of leukaemia treatment. Targeted therapy has also been included in the
standard of care for certain kinds of leukaemia within the past 20 years. These
medications target the proteins that regulate the growth, division, and metastasis of
cancer cells. Different treatment combinations are needed for different forms of
leukaemia.
For Acute lymphocytic leukemia (ALL), Immunotherapies are being used where
many elderly people are unable to handle the severe side effects of the intense
chemotherapy therapies required to treat ALL. Compared to chemotherapy, targeted
therapies might have fewer adverse effects.
Immunotherapies are treatments that enhance the body's ability to fight cancer
through the immune system. Currently, four immunotherapies are FDA approved for
the treatment of ALL: blinatumomab, inotuzumab ozogamicin, tisagenlecleucel and
midostaurin. In ALL, the following immunotherapy techniques are being tested or
employed are CAR T-cell therapy and bispecific T-cell engagers (BiTEs). A sort of
cancer treatment called CAR T-cell therapy involves genetically modifying the
patient & own immune cells. For the treatment of some children and young adults with
ALL, one kind of CAR T cell therapy is currently approved. Dosing is based on
weight reported at the time of leukapheresis.The use of this type in elderly B-cell
ALL patients is now being investigated. Adults with B-cell precursor ALL who have
not responded to previous treatment or have returned after treatment have been
approved for another course of CAR T-cell therapy.
Bispecific T-cell engagers (BiTEs) are another immunotherapy that is being studied
for ALL. These medications bind to both cancer and immune cells, drawing the two
groups of cells closer together so that the immune cells can locate and eliminate the
cancer cells with ease. Recently, it was demonstrated that one such BiTE,
blinatumomab, can increase survival for ALL patients in remission following
chemotherapy, even in situations where the disease is completely eradicated.
Acute myeloid leukaemia (AML) tends to be aggressive and was harder to treat than
ALL. However, AML cells sometimes have gene changes that cause the tumors to
grow but can be targeted with new drugs. The management of AML involves two
phases such as remission induction therapy (first phase of treatment to kill
the leukemia cells in the blood and bone marrow ) and remission continuation therapy
(second phase of treatment to kill any remaining leukemia cells).
The treatment of AML includes chemotherapy (drugs to stop the growth of cancer
cells), radiation therapy (uses high-energy x-rays or other types of radiation to kill
cancer cells), stem cell transplant (to replace the blood-forming cells from the blood
or bone marrow of the patient) and targeted therapy (drugs or other substances to
identify and attack specific cancer cells) or combination of both. Targeted treatments
such as Enasidenib, Olutasidenib, Ivosidenib, Venetoclax, Gemtuzumab ozogamicin,
Midostaurin, Gilteritinib, Glasdegib, and Quizartinib have recently been approved to
treat AML with specific gene alterations.
In order to achieve complete remission (CR) from acute leukaemia, standard
treatment paradigms have involved high-intensity induction chemotherapy. In certain
cases, this was followed by an allogeneic hematopoietic cell transplant (allo-HCT) to
eliminate residual disease through the "graft versus leukaemia effect, which is
mediated by the immune cells of the donor. Allo-HCT is not recommended for all
patients, though, and one of the biggest problems facing the industry at the moment is
the lack of viable chemotherapy-based choices for patients who relapse after allo-
HCT or who develop chemotherapy-refractory illness.
The potential of immunotherapy in the treatment of acute myeloid leukaemia (AML)
has been established by the effectiveness of allogeneic stem cell transplantation.
Alternative T-cell-based immunotherapies have demonstrated effectiveness, but there
is a chance that they could cause on-target off-leukemia hematotoxicity. Currently,
the use of adoptive autologous or allogeneic chimeric antigen receptor (CAR) T /
natural killer cell treatment as a bridge-to-transplant approach is almost only available
in clinical studies.
Acute leukaemia used to be nearly always fatal, but now it has a 63% 5-year survival
rate in the US. The therapeutic options for acute leukaemia have increased with the
introduction of immunotherapy, however, the advancement in AML has been slower.
Novel medicines such as ADCs, CAR T cell treatments, and BiTEs continue to show
remarkable response rates and favourable toxicity profiles in various disease states
every year. Even with these developments, a large number of patients are still not
eligible for immunotherapeutic treatments, and relapses following some of the more
recent modalities are still linked to extremely poor prognoses. In the future, new
medicines with potentially unique mechanisms of action will probably be approved
together with the expansion of the indications for currently available medications.
References:
1. Leukemia. National Cancer Institute. Available at:
https://www.cancer.gov/types/leukemia/hp/adult-aml-treatment-pdq
2. Boyiadzis MM, Aksentijevich I, Arber DA, et al. The Society for Immunotherapy
of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of
acute leukemia. Journal for ImmunoTherapy of Cancer. 2020
3. Kantarjian, H., Kadia, T., DiNardo, C. et al. Acute myeloid leukemia: current
progress and future directions. Blood Cancer J. 2021
4. Subklewe M, Bücklein V, Sallman D, Daver N. Novel immunotherapies in the
treatment of AML: is there hope? Hematology Am Soc Hematol Educ Program. 2023
Dec 8;2023
Share:
More Posts
Can Lifestyle Choices Reduce the Risk of Thyroid Cancer?
Thyroid cancer is one of the fastest-growing cancers worldwide, with an increasing number of cases being diagnosed every year. At Healius Cancer & Hematology Clinics, we believe that awareness and proactive steps can make a big difference in early detection, better outcomes, and healthier living. Understanding Thyroid Cancer The thyroid gland, often called the “butterfly gland,” plays a vital role in regulating metabolism and hormones. When abnormal cells begin to grow in this gland, it can lead to thyroid cancer. Common thyroid cancer symptoms include: Recognizing these signs early and undergoing thyroid cancer screening can help in timely diagnosis and treatment. Thyroid Cancer in Women Studies show that thyroid cancer in women is more common than in men, especially between the ages of 30 and 50. Hormonal factors, lifestyle, and genetic predispositions may play a role. Regular check-ups are highly recommended for women with a family history of thyroid disease. Can Lifestyle Reduce Risk? While not all thyroid cancers can be prevented, certain lifestyle choices may lower the risk and improve overall thyroid health: Thyroid Cancer Survival Rate The good news is that the thyroid cancer survival rate is among the highest compared to other cancers, especially when diagnosed early. With advancements in thyroid cancer treatment, including surgery, radioactive iodine therapy, and targeted therapies, many patients go on to live long, healthy lives. How Healius Can Help At Healius Cancer & Hematology Clinics, we provide: Final Thoughts While lifestyle changes alone cannot guarantee prevention, they play a vital role in lowering risk, improving health, and supporting recovery. Combined with timely thyroid cancer screening and expert care, early detection remains the key to better outcomes. At Healius, our team of oncologists and hematologists is dedicated to providing the best thyroid cancer treatment with compassion and expertise. If you or a loved one notice any thyroid cancer symptoms, don’t delay. Book a consultation at Healius Cancer & Hematology Clinics today for expert guidance and screening. Contact : +91 9900613143 Location : Banashankari 2nd stage, Bangalore
Targeted Therapies & Immunotherapy: The Future of Blood Cancer Care
Blood cancer is one of the most challenging cancers, but recent breakthroughs in targeted therapies and immunotherapy are changing the way patients are treated. These advanced approaches not only improve survival rates but also reduce side effects compared to traditional chemotherapy. At Healius Cancer & Hematology Clinics, we are committed to bringing world-class cancer care closer to patients, making us one of the most trusted blood cancer treatment centers in Bangalore. Understanding Blood Cancer and Its Symptoms Blood cancers like leukemia, lymphoma, and myeloma affect the blood, bone marrow, or lymphatic system. Early detection makes a significant difference. Common blood cancer symptoms in Bangalore patients include: How Targeted Therapies Work Unlike chemotherapy, which attacks both healthy and cancerous cells, targeted therapies focus only on the specific cancer-causing genes, proteins, or tissues. This makes treatment more effective and reduces side effects. At Healius, our oncology team uses advanced molecular diagnostics to determine whether targeted therapy is suitable for each patient, ensuring a personalized approach to care. Immunotherapy – Harnessing the Power of the Immune System Immunotherapy activates the body’s own immune system to fight cancer cells. One of the most promising advances is CAR-T cell therapy in Bangalore, where a patient’s T-cells are engineered to better recognize and destroy cancer cells. This breakthrough is especially effective in certain types of leukemia and lymphoma. Specialized Care for Lymphoma and Bone Marrow Transplants At Healius, our lymphoma specialists in Bangalore provide expert guidance on treatment options tailored to each patient’s needs. For advanced cases, we also offer bone marrow transplant in Bangalore, a life-saving procedure that replaces diseased marrow with healthy stem cells, offering hope for long-term remission. Why Choose Healius? Final Thoughts The future of blood cancer care lies in precision medicine – and targeted therapies and immunotherapy are at the heart of this transformation. At Healius Cancer & Hematology Clinics, we are dedicated to providing patients with the latest treatment innovations, compassionate care, and hope for tomorrow. If you or a loved one is experiencing blood cancer symptoms in Bangalore, don’t wait. Book an appointment with our experts at Healius Cancer & Hematology Clinics today and consult with the best hematologists in Bangalore for world-class treatment. Contact: +91 9900613143 Location: banashankari, 2nd stage
Why Ovarian Cancer is Called the ‘Silent Killer’
Ovarian cancer is often referred to as the “silent killer” because it usually develops without obvious warning signs in its early stages. By the time symptoms become noticeable, the disease is often advanced, making treatment more challenging. At Healius Cancer & Hematology Clinics, we are committed to raising awareness, improving early detection, and providing world-class treatment options, making us one of the best ovarian cancer hospitals in Bangalore. Why Early Symptoms Are Overlooked Ovarian cancer often presents with vague and non-specific symptoms such as: These signs are often mistaken for digestive or urinary issues, which delays diagnosis. This is why awareness and preventive screenings are so crucial. The Importance of Early Detection Unlike other cancers, there is no reliable routine screening test for ovarian cancer. Regular checkups with specialized ovarian cancer doctors in Bangalore are essential, especially for women with family history or genetic risk factors (like BRCA mutations). Early detection significantly improves treatment outcomes and survival rates. Advanced Treatment Options at Healius At Healius, we bring together advanced technology and experienced specialists to provide comprehensive ovarian cancer care: 1. Robotic Surgery for Ovarian Cancer Minimally invasive robotic surgery for ovarian cancer in Bangalore allows greater precision, less blood loss, faster recovery, and smaller scars compared to traditional surgery. This cutting-edge technique ensures patients have access to the best surgical outcomes. 2. Chemotherapy for Ovarian Cancer Chemotherapy for ovarian cancer remains a cornerstone of treatment, targeting cancer cells throughout the body. At Healius, patients receive personalized chemotherapy plans under close monitoring to minimize side effects and maximize effectiveness. 3. Multidisciplinary Care Our team of oncologists, hematologists, and surgeons work together to design individualized treatment plans. This holistic approach ensures that every patient receives not just treatment, but also emotional and nutritional support throughout their journey. Why Choose Healius? Final Thoughts Ovarian cancer may be called the “silent killer,” but with increased awareness, timely consultation, and advanced treatment options, it doesn’t have to remain silent anymore. At Healius Cancer & Hematology Clinics, we stand by women at every stage — from early detection to recovery — ensuring compassionate care backed by the latest medical innovations. If you or a loved one is experiencing persistent symptoms, consult the expert ovarian cancer doctors in Bangalore at Healius Cancer & Hematology Clinics today. Early action saves lives. Book an appointment: +91 9900613143 Location: Banashankari 2nd stage, Bangalore 560070
Leukemia & Lymphoma in Children vs. Adults: What You Need to Know
Leukemia & Lymphoma in Children vs. Adults: What You Need to Know Leukemia and lymphoma are two of the most common types of blood cancers. While they can occur at any age, the way these diseases present and progress in children vs. adults often differs. Understanding these differences is key to early detection and effective treatment. At Healius Cancer & Hematology Clinics, Bangalore, we provide comprehensive care including blood cancer treatment in Bangalore, chemotherapy at economical cost, and radiation therapy in Bangalore to support patients at every stage of their journey. Causes & Risk Factors Though the exact causes of leukemia and lymphoma are not always known, several risk factors have been identified: Genetic predisposition – Family history of blood cancers increases the risk. Weakened immune system – Conditions like HIV or immune-suppressing treatments may lead to higher vulnerability. Environmental exposure – Prolonged exposure to radiation or harmful chemicals can trigger changes in blood cells. Age-related factors – Certain leukemias are more common in children (like acute lymphoblastic leukemia), while others are seen more in adults (like chronic lymphocytic leukemia). Symptoms to Watch For The symptoms may vary in children and adults, but some common warning signs include: Persistent fatigue and weakness – Low red blood cells cause anemia and constant tiredness. Unexplained fever and frequent infections – A weak immune system leads to repeated illness. Swollen lymph nodes or abdomen – Enlarged nodes or spleen can indicate lymphoma or leukemia progression. Easy bruising or bleeding – Platelet deficiency causes nosebleeds, gum bleeding, or unusual bruises. If you notice these symptoms in yourself or your child, seek specialized hematology consultation in Bangalore immediately. Treatment Options at Healius At Healius Cancer & Hematology Clinics, we offer advanced yet affordable treatments tailored for both children and adults: Chemotherapy at economical cost – Targeted medications to destroy cancer cells while minimizing side effects. Radiation therapy in Bangalore – Advanced technology to treat lymphomas effectively and safely. Immunotherapy & Targeted Therapy – Modern approaches to boost the immune system and attack only cancerous cells. Bone Marrow Transplant referrals & support – For cases where intensive treatment is required. Why Choose Healius? Expert Oncologists & Hematologists led by Dr. Mangesh Kamath with vast experience in blood cancer treatment. Affordable care with chemotherapy at economical cost and accessible treatment plans. Personalized approach for children and adults with age-specific treatment protocols. Comprehensive support including nutrition counseling, rehabilitation, and caregiver guidance. At Healius, we combine compassionate care with world-class medical expertise to give patients the best chance of recovery. Contact Us – Begin the Journey of Healing Location: Healius Cancer & Hematology Clinics, Banashankari 2nd stage, BangaloreContact: +91 9900613143 Website: www.healiuscancerhematology.com If you or your loved one is looking for blood cancer treatment in Bangalore, trust Healius for advanced care, affordable treatment options, and expert guidance. Conclusion Early detection and timely treatment save lives. This Leukemia & Lymphoma Awareness Month, let’s spread awareness and give hope to those fighting blood cancers. Book an Appointment
